Psychedelic Music Studio Closes $4.5M Seed Round: The Birth Of Psychedelics Ancillary?

As the psychedelic medicine sector progresses, institutional investors are finding opportunities in companies that provide products and services surrounding the sector’s core operations.

Growing institutional support for ancillary companies can be seen as clear proof of a sector’s path towards maturity as investors look for ways of exploiting opportunities inherent to a booming ecosystem.

The latest company to benefit from this trend is Wavepaths, a music studio dedicated to the creation of music to accompany psychedelic therapy, which on Thursday closed a $4.5 million seed investment round.

The company, co-founded by Dr. Mendel Kaelen and Anna Wakefield in 2019, is described as “a digital platform that builds upon pioneering scientific research showing that music plays an essential role in creating positive outcomes for psychedelic therapies.”

The platform offers customizable music that can be used to benefit the therapeutic outcomes of “trips” with ketamine, psilocybin and MDMA, among other similar drugs.

“Music has a profound impact on therapeutic outcomes, but many therapists are in the dark on how to best work with music in their practice,” said Kaelen. “Our adaptive music technology enables care providers to work with music in a fully person-centered way, with the same ease by which one may adapt the temperature or light in the room.”  

The company stated in a press release that it has worked with a variety of musical artists to create an AI-powered auditory landscape designed to be responsive to every moment of a therapy session.

“During sessions, the platform’s interface allows practitioners to seamlessly transition between emotional atmospheres, levels of depth and activation, and instrumentation in real time, based on a patient’s evolving mood or therapeutic needs,” noted the company.

Photo by Dylan McLeod on Unsplash.

Posted In: WavepathsCannabisPsychedelicsMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.